Allison Bentley, senior director of strategic programs at GNC Health, shares why now is the right time for the global wellness brand to expand into digitized health care.
The FDA has approved Eli LIlly's Zepbound for chronic weight management in adults with obesity, in addition to a reduced calorie diet and increased physical activity.
The ERISA Industry Committee has submitted a comment letter to the Ohio House of Representatives Insurance Committee urging the panel to amend House Bill 291 to include access to all biosimilar products.